尼罗罗非鱼生长激素及其受体的cDNA克隆与mRNA表达的雌雄差异

尼罗罗非鱼(Oreochromis niloticus)雌雄鱼生长差异明显,为了探讨其原因,本文采用RT-PCR方法克隆了尼罗罗非鱼生长激素(Growthhormone,GH)及其受体(Growth hormone receptor,GHR)的cDNA序列,并应用半定量RT-PCR方法比较了雌、雄尼罗罗非鱼垂体GHmRNA、肝脏GHRmRNA、肌肉GHRmRNA的表达差异。序列分析表明:GH开放阅读框为615bp,共编码204个氨基酸;GHR开放阅读框为1908bp,共编码635个氨基酸。以RT-PCR方法研究了GH、GHR在各组织的分布情况,结果表明:GH仅在垂体中检测到有表达,而GHR在所检测的18种组织中均有表达,其中以肝脏、肌肉、性腺、下丘脑、胸腺表达量较高。以半定量RT-PCR方法进一步比较了雌、雄尼罗罗非鱼垂体GHmRNA、肝脏GHRmRNA、肌肉GHRmRNA的表达量,结果表明:雄鱼垂体GHmRNA和肝脏GHRmRNA的表达量均显著高于雌鱼,肌肉GHRmRNA的表达量则无显著差异,推测垂体GHmRNA和肝脏GHRmRNA表达的雌雄差异是尼罗罗非鱼雌雄生长差异的主要原因之一。     

IGF—ImRNA在不同年龄鲤表达的差异和LHRH—A对IGF—ImRNA表达的影响

利用RNA酶保护法对7月龄性未成熟幼鲤和2龄性成熟鲤组织胰岛素样生长因子-I（IGF-I）mRNA的表达水平进行测定,结果表明成鱼肝和肾脏组织IGF-ImRNA的丰度显著高于幼鱼,对鲤成鱼和幼鱼腹腔注射促性腺激素释放激素类似物（LHRH-A,D-Ala^6-Pro^9-NEt-LHRH)使血清生长激素（GH）水平和肝组织IGF-ImRNA水平都显著升高,而成鱼生殖腺IGF-ImRNA的丰度比对照组显著增加,研究结果提示鲤在不同发育阶段肝组织IGF-ImRNA的丰度比对照组显著增加,研究结果提示鲤在不同发育阶段肝组织IGF-ImRNA的表达存在差别,其中2龄成鱼大于7月龄幼鱼;LHRH-A可能通过刺激垂体GH的释放间接促进肝组织IGF-ImRNA的表达,亦可能通过某种未知途径刺激生殖腺IGF-ImRNA的表达。     

重组生长激素对猪生长激素受体和胰岛素样生长因子1基因表达及血清瘦蛋白水平的影响

16头长白×大约克去势公猪, 随机分成试验组和对照组, 每天注射重组猪生长激素(rpGH, 每头每天4 mg) 或生理盐水, 28 d后采样. 用RIA法测定血清中胰岛素样生长因子1(IGF-Ⅰ)和瘦蛋白含量, 用反转录多聚酶链式反应(RT-PCR)方法, 以18S rRNA作内标, 定量分析肝脏、肌肉生长激素受体 (GHR) 和IGF-ⅠmRNA的相对丰度.结果显示: (ⅰ) 试验组平均日增重提高26.1% ( P <0.05); (ⅱ)血清IGF-Ⅰ水平提高70.94% (P<0.01), 血清瘦蛋白降低34.80%(P<0.01); (ⅲ) 肝脏GHR mRNA增加24.45% (P < 0.05), IGF-ⅠmRNA增加45.30% (P<0.01), 背最长肌GHR和IGF-Ⅰ mRNA表达无明显变化. 结果表明, 重组猪生长激素能明显提高生长猪生长性能. 上调肝脏GHR, 促进肝脏产生IGF-Ⅰ, 而对肌肉GHR和IGF-I基因表达无影响, 提示重组GH对基因表达的影响有组织特异性.     

奥尼罗非鱼及其亲本感染无乳链球菌后生理响应变化

研究通过比较杂交子一代奥尼罗非鱼(Oreochromis spp.)与亲本在腹腔注射无乳链球菌(Streptococcus agalactiae)后累积死亡率差异, 血液生理指标、生化指标和脾脏促炎性细胞因子的表达水平变化, 以深入了解奥尼罗非鱼抗病性杂种优势的生理和分子基础。结果显示: 在无乳链球菌人工感染后, 奥尼罗非鱼的累积死亡率显著低于亲本(P<0.05)。感染前奥尼罗非鱼的白细胞数、红细胞数和红细胞压积最高, 感染后3种罗非鱼的白细胞都显著性升高(P<0.05), 红细胞数、红细胞压积和血红蛋白显著性下降(P<0.05), 呼吸暴发受到抑制, 奥尼罗非鱼血液生理指标与父本奥利亚罗非鱼更为接近; 奥尼罗非鱼在感染细菌后的血糖浓度和溶菌酶含量显著高于亲本, 呼吸暴发强于亲本(P<0.05)。定量PCR结果显示感染后3种罗非鱼脾脏TNF-α、IL-1β和IL-6的mRNA表达水平都显著上升(P<0.05), 3种罗非鱼的TNF-α和IL-6都在感染后7h达到峰值, 奥尼罗非鱼IL-1β在感染后48h达到峰值, 尼罗罗非鱼IL-1β在感染后24—48h达到峰值, 奥利亚罗非鱼IL-1β在感染后72h达到峰值; 奥尼罗非鱼的TNF-α和IL-6 mRNA表达水平在感染前后都最高, IL-1β mRNA表达水平在感染前和感染后7—48h显著高于亲本(P<0.05)。研究表明杂交育种途径能显著提高鱼体的抗病力, 与亲本相比, 奥尼罗非鱼对无乳链球菌的侵染具有更强的防御能力; 感染后3种罗非鱼促炎性细胞因子都显著升高, 可能参与了宿主对细菌感染的防御, 但奥尼罗非鱼的免疫应答比亲本更活跃, 表现出抗病力杂种优势。     

GSK4112对尼罗罗非鱼肝脏Nr1d1和Ulk1b基因昼夜节律性表达的影响

为了探究GSK4112对生物钟以及自噬基因在尼罗罗非鱼(Oreochromis niloticus)肝脏的昼夜表达规律的作用.本试验分别对尼罗罗非鱼注射等量生理盐水和GSK4112,并在注射24h后的06:00、09:00、12:00、15:00、18:00、21:00、24:00时以及翌日03:00、06:00时采样,采样在一昼夜内完成.每组随机取3尾鱼进行解剖,取其肝脏样品采用RT-qPCR对mRNA表达水平,进行Matlab余弦分析,确定其节律性表达,并将注射前后肝脏样品用透射电镜检测自噬小体数量变化.结果表明:生物钟基因Nr1d1与自噬基因Ulk1b在对照组的尼罗罗非鱼肝脏中表达均具有显著性时间差异(P＜0.05),且均呈现节律性振荡(P＜0.3);但基因表达趋势不同,且达到峰值的时间亦不同.注射Nr1d1激动剂GSK4112后Nr1d1与Ulk1b在尼罗罗非鱼肝脏中均无昼夜节律性,虽然达到峰值的时间不同,但基因表达趋势相同,mRNA表达水平均表达量受到抑制,振幅和中值减小,且自噬小体数量也减少.这些结论表明了GSK4112在尼罗罗非鱼肝脏中对生物钟基因Nr1d1的表达起到抑制作用,同时影响其生物节律性.通过对下游自噬基因Ulk1b的昼夜节律调控,抑制自噬小体的数量,降低自噬的发生.本研究对鱼类由昼夜节律失调引起的自噬失调可能导致常见的代谢紊乱具有指导作用.     

GnRH类似物对子宫肌瘤大鼠模型血液黏度、子宫系数和炎性细胞浸润的影响

摘要 目的：探讨促性腺激素释放激素（Gonadotropin releasing hormone,GnRH）类似物对子宫肌瘤大鼠模型血液黏度、子宫系数和炎性细胞浸润的影响。方法：子宫肌瘤大鼠模型（n=36）随机平分为三组-模型组、米非司酮组与GnRH类似物组,分别给予腹腔注射0.15 ml的生理盐水、2 mg/kg米非司酮与2 mg/kg GnRH类似物,每周1次,持续8周。结果：米非司酮组与GnRH类似物组治疗第4周与第8周的全血比黏度、卵泡刺激素（FSH）、黄体生成素（LH）值都低于模型组（P<0.05）,GnRH类似物组低于米非司酮组（P<0.05）。米非司酮组与GnRH类似物组治疗第8周的子宫系数、子宫白介素（IL）-10与肿瘤坏死因子（TNF）-α表达水平都低于模型组（P<0.05）,GnRH类似物组低于米非司酮组（P<0.05）。米非司酮组与GnRH类似物组治疗第8周的子宫内膜厚度、腺间质面积比、腺体面积与腺腔面积都高于模型组（P<0.05）,GnRH类似物组高于米非司酮组（P<0.05）。米非司酮组与GnRH类似物组治疗第8周的子宫组织Wnt5b与β-catenin蛋白相对表达水平低于模型组（P<0.05）,GnRH类似物组低于米非司酮组（P<0.05）。结论：GnRH类似物在子宫肌瘤大鼠模型的应用能降低子血液黏度,还可抑制血清性激素的分泌,增加子宫系数,抑制Wnt5b与β-catenin蛋白的表达,从而可改善子宫肌瘤大鼠的炎性细胞浸润状态与子宫内膜形态。     

GH受体、IGF-I型受体、FSH受体和LH受体mRNA在绍鸭各级卵泡颗粒层和膜层中的表达

采用相对定量反转录多聚酶链式反应(RT-PCR)的方法,以β-actin为内标,测定绍鸭排卵前卵泡F1、F3、F5及大白卵泡(LWF)颗粒层与膜层中GH受体(GHR)、IGF-I型受体(IGF-IR)和FSH受体(FSHR)、LH受体(LHR)mRNA表达水平,以分析生长轴和生殖轴激素对绍鸭卵泡发育的协同调节作用。结果表明：在所测定的各级卵泡中,GHR mRNA在膜层的表达水平均显著高于颗粒层,膜层中大白卵泡表达量最高,而颗粒层中GHR mRNA水平在各级卵泡之间没有明显差异;相反,IGF-IR mRNA在同级卵泡颗粒层的表达水平显著高于膜层,颗粒层和膜层中IGF-IR mRNA表达在各级卵泡之间的差异均不显著,只是大白卵泡的膜层与其他等级卵泡的膜层相比,IGF-IR的表达量呈现较高的趋势;FSHR mRNA表达的变化趋势类似于IGE-IR,同级卵泡颗粒层中的表达量高于膜层;LMR mRNA在各级卵泡膜层中表达没有明显差异,而颗粒层中IMR mRNA随着卵泡发育成熟逐级显著增加,且F5和LWF卵泡膜层的IMR mRNA显著高于颗粒层,与GHR mRNA的表达相似。结果提示,GH和IGF-I调节卵巢功能的优势作用位点和机制不尽相同;GHR和LHR协同表达与IGF-IR和FSHR协同表达可能对卵泡发育起到精细的调节作用;而IMR在卵泡颗粒层中表达的逐级显著增加可能与卵泡等级的建立和排卵有关。     

温度、盐度及其互作效应对吉富罗非鱼血清IGF-I与生长的影响

采用中心复合试验设计和响应曲面分析方法,在实验室条件下,探讨了温度(18-37℃)、盐度(0-18)及其互作效应对吉富罗非鱼幼鱼血清IGF-I、生长和饲料效率的影响,并且分析了血清IGF-I与生长、饲料效率的关系.整个试验持续8周.结果表明,温度的一次与二次效应对血清IGF-I、生长和饲料效率有显著影响,盐度的一次与二次效应对血清IGF-I和生长有显著影响.高温与高盐环境会降低罗非鱼的生长与饲料效率.血清IGF-I随水温的上升呈先上升后下降的变化;在等渗点附近,罗非鱼血清IGF-I水平较低.血清IGF-I与生长和饲料效率具有相关性,血清IGF-I水平较高时,特定生长率和饲料效率均较高.温度和盐度的互作效应对血清IGF-I、生长和饲料效率无显著影响(P＞0.05).温度和盐度分别为28.5℃和8.4时,特定生长率和饲料效率同时达到最优值,为2.29％/d和0.82,其可靠性为0.937.低盐环境可以提高罗非鱼的生长与饲料利用,血清IGF-I水平的升高有助于增强罗非鱼渗透调节能力.     

水体pH对尼罗罗非鱼生长、营养组成和肉质的影响

为研究水体pH对尼罗罗非鱼(Oreochromis niloticus)生长、营养组成和肉质的影响, 实验设置低pH(Low pH: 4)、对照(Control: 7.2)和高pH(High pH: 8.5)三个水体pH梯度, 投喂初重为(1.9±0.1)? g的尼罗罗非鱼10周, 并测定其生长性能、血清生化指标、肌肉营养成分和肉质相关指标。结果显示, 相较于对照组, 高pH和低pH水环境造成尼罗罗非鱼的增重率显著降低(P<0.05), 肝糖原累积显著增高(P<0.05), 同时也造成血清中甘油三酯的含量显著降低(P<0.05)及肝功能指标血清谷草转氨酶、谷丙转氨酶的活性显著增高(P<0.05)。另外, 高pH水环境导致尼罗罗非鱼脏体比和肌肉黏性显著降低(P<0.05), 肌肉蒸煮损失、肌肉和血清中乳酸含量显著增高(P<0.05)。同时, 高pH组罗非鱼肌肉的PUFA, 特别是n-3 PUFA的相对含量显著提高(P<0.05), 肌肉脂肪酸营养价值得到提升。而低pH水环境则会造成罗非鱼的脏体比和饲料系数显著提高(P<0.05), 及肌肉弹性的显著降低(P<0.05)。综上所述, 尽管高pH水环境会使罗非鱼肌肉中n-3 PUFA含量有所提高, 但是整体来看, 高或低pH水环境均不利于尼罗罗非鱼的健康生长和肌肉品质的提升。     

四个罗非鱼选育品种抗链球菌病能力差异研究

为筛选出抗病力优良的罗非鱼品种, 以奥利亚罗非鱼“夏奥1号”、尼罗罗非鱼“99”埃及品系、吉富罗非鱼“中威1号”和奥尼罗非鱼为研究对象, 33℃水温暂养7d后分别进行无乳链球菌人工感染实验, 连续7d统计累计死亡率, 并于人工感染后0、24h、48h和72h采集血液和组织样本, 研究这4个罗非鱼选育品种抗链球菌病能力的差异。结果显示: 感染7d后奥尼罗非鱼的累计死亡率最低; 奥尼罗非鱼的谷草转氨酶(AST)感染前后始终都低于其余3个品种罗非鱼(P<0.05); 埃及尼罗和奥尼在感染72h后球蛋白(GLO)分别显著升高1.13倍和1.41倍; 奥尼罗非鱼白蛋白/球蛋白(A/G)在感染前后没有显著性变化(P>0.05), 而其余3个品种罗非鱼A/G比值在感染后都显著性降低(P<0.05); 埃及尼罗的碱性磷酸酶(AKP)在感染72h后显著降低(P<0.05), 奥利亚和吉富的AKP表现为先上升后下降, 奥尼的AKP感染前后没有显著性变化(P>0.05); 各品种罗非鱼血清中的乳酸脱氢酶(LDH)感染后都显著升高(P<0.05); 奥利亚、吉富和奥尼罗非鱼的超氧化歧化酶(SOD)感染48h时都显著升高(P<0.05); 奥尼罗非鱼在感染前后溶菌酶(LZM)活性都显著高于其余3个品种罗非鱼(P<0.05)。组织病理学结果显示:吉富和奥尼肝细胞水肿变性, 而奥利亚和埃及尼罗出现大面积肝细胞脂肪变性; 每个品种罗非鱼均呈现严重的脾炎, 奥利亚、埃及尼罗和吉富的脾脏中大量铁血黄素沉积; 每种罗非鱼呈现不同程度的肾小球萎缩, 肾小管上皮细胞变性、坏死。研究表明奥尼罗非鱼抗链球菌病能力最强, 感染后血清中AST水平与肝受损程度呈一定的正相关, LZM水平和罗非鱼抗链球菌病能力呈一定的正相关。     

Effect of recombinant growth hormone on expression of growth hormone receptor,insulin-like growth factor mRNA and serum level of leptin in growing pigs

Sixteen Large White × Landrace castrated male pigs were allotted into treatment and control group. The treatment group was injected intramuscularly with recombinant porcine growth hormone (rpGH, 4 mg d⁻¹) and the control group with vehicle for 28 days. Animals were slaughtered 4 h after final injection for liver, longissimus dorsi (LD) muscle and blood sampling. Serum concentration of insulin-like growth factor 1 (IGF-I) and leptin were determined by RIA. The total RNA was extracted from tissues to measure the abundance of growth hormone receptor (GHR), IGF-I mRNA by RT-PCR with 18S rRNA internal standard. Results showed that rpGH enhanced the average daily weight gain by 26.1% (P < 0.05), the serum IGF-I concentration by 70.94% (P < 0.01), decreased serum leptin by 34.8% (P < 0.01). The relative abundance of GHR and IGF-I mRNA in liver were increased by 24.45% (P < 0.05) and 45.30% (P < 0.01), respectively, but no difference of GHR (P > 0.05) and IGF-I mRNA (P > 0.05) in LD between GH treated and control group was found. These results suggest that rpGH can up-regulate hepatic GHR and IGF-I gene expression and improve animal growth. However the effect of rpGH on GHR and IGF-I gene expression are tissue-specific.     

Growth hormone (GH) treatment acts on the endocrine and autocrine/paracrine GH/IGF-axis and on TNF-α expression in bony fish pituitary and immune organs

There exist indications that the growth hormone (GH)/insulin-like growth factor (IGF) axis may play a role in fish immune regulation, and that interactions occur via tumour necrosis factor (TNF)-α at least in mammals, but no systematic data exist on potential changes in GH, IGF-I, IGF-II, GH receptor (GHR) and TNF-α expression after GH treatment. Thus, we investigated in the Nile tilapia the influence of GH injections by real-time qPCR at different levels of the GH/IGF-axis (brain, pituitary, peripheral organs) with special emphasis on the immune organs head kidney and spleen. Endocrine IGF-I served as positive control for GH treatment efficiency. Basal TNF-α gene expression was detected in all organs investigated with the expression being most pronounced in brain. Two consecutive intraperitoneal injections of bream GH elevated liver IGF-I mRNA and plasma IGF-I concentration. Also liver IGF-II mRNA and TNF-α were increased while the GHR was downregulated. In brain, no change occurred in the expression levels of all genes investigated. GH gene expression was exclusively detected in the pituitary where the GH injections elevated both GH and IGF-I gene expression. In the head kidney, GH upregulated IGF-I mRNA to an even higher extent than liver IGF-I while IGF-II and GHR gene expressions were not affected. Also in the spleen, no change occurred in GHR mRNA, however, IGF-I and IGF-II mRNAs were increased. In correlation, in situ hybridisation showed a markedly higher amount of IGF-I mRNA in head kidney and spleen after GH injection. In both immune tissues, TNF-α gene expression showed a trend to decrease after GH treatment. The stimulation of IGF-I and also partially of IGF-II expression in the fish immune organs by GH indicates a local role of the IGFs in immune organ regulation while the differential changes in TNF-α support the in mammals postulated interactions with the GH/IGF-axis which demand for further investigations.     

Effect of recombinant growth hormone on expression of growth hormone receptor, insulin-like growth factor mRNA and serum level of leptin in growing pigs

Growth hormone (GH) plays an important role in regulation of animal growth, metabolism and lactation[1]. Numerous studies have shown that exogenous somatotropin (ST) can increase average daily weight gain, improve feed efficiency, stimulate protein deposition and muscle growth and decrease lipid accretion rate[1]. The original somatomedin hypothesis suggested that the effect of GH on postnatal growth was mediated by insulin-like growth hormone factor 1 (IGF-I) which was thought to be deriv…     

Effects of homologous ghrelins on the growth hormone/insulin-like growth factor-I axis in the tilapia, Oreochromis mossambicus

Ghrelin is a gut-brain peptide synthesized mainly in the oxyntic mucosal cells of the stomach, and has potent growth hormone (GH)-releasing and orexigenic activities. Recently, two forms of ghrelin, ghrelin-C8 and -C10, were identified in the Mozambique tilapia (Oreochromis mossambicus). The present study describes in vitro and in vivo effects of these endogenous ghrelins on the GH/insulin-like growth factor-I (IGF-I) axis. Ghrelin-C8 (100 nM) stimulated GH release from primary cultures of pituitary cells after 4 and 8 h of incubation, whereas no effect was seen on prolactin (PRL) release. Stimulatory effects of ghrelin-C8 and -C10 (100 nM) on GH release during 6 h of incubation were blocked by pre-incubation with GHS receptor antagonist, [D-Lys(3)]-GHRP-6 (10 microM). Intraperitoneal injection of ghrelin-C8 (1 ng/g body weight) and -C10 (0.1 and 1 ng/g body weight) significantly increased plasma GH levels after 5 h. Significant increases were observed also in hepatic expression of IGF-I and GH receptor (GHR) mRNA following injections of both forms of ghrelin (0.1 and 1 ng/g body weight), although there was no effect on plasma levels of IGF-I. In the next experiment, both forms of ghrelin (1 ng/g body weight) significantly increased plasma IGF-I levels 10 h after the injection. No significant effect of either ghrelin was observed on plasma PRL levels. Both forms of GHS receptor (GHSR-1a and -1b) were found in the pituitary, clearly indicating that tilapia ghrelins stimulate primarily GH release through the GHS receptor. Stimulation of hepatic expression of IGF-I and GHR suggests metabolic roles of ghrelin in tilapia.     

黄颡鱼重组生长激素的制备及对其鱼苗生长的影响

生长激素在渔业生产中具有重要的应用价值, 通过制备黄颡鱼(Pelteobagrus fulvidraco)同源重组生长激素并用于促生长实验, 从而为建立鱼苗快速培育方法提供理论依据。根据已知黄颡鱼生长激素(PfGH)基因cDNA序列, 利用IPTG诱导和SDS-PAGE分析方法, Western印迹表明在IPTG终浓度1.0 mmol/L、温度17℃和培养时间14h的条件下, 黄颡鱼生长激素基因在大肠杆菌中大量表达, 获得重组生长激素蛋白。然后, 随机选取黄颡鱼分为4组放入室内水族箱中进行养殖, 每箱35尾, 体质量为(0.850.01) g, 每组设3个平行, 水体循环净化。用制备的重组生长激素浓度分别为0、1、5和10 mg/L对黄颡鱼进行浸泡处理, 每周一次, 0为对照组。在养殖4周后, 对各组增重率和特定生长率进行比较, 结果表明1 mg/L组增重率和特定生长率分别比对照组提高了29.67% (P0.05)和11.90% (P0.05), 5 mg/L组增重率和特定生长率分别比对照组提高了21.32% (P0.05)和8.83% (P0.05), 各组间体成分等均无明显差异。停用生长激素4周后, 各组黄颡鱼的生长性能、体成分等均无显著差异。研究表明通过原核表达可以获得黄颡鱼重组生长激素, 用于促进鱼苗生长培育的最佳浸泡浓度为1 mg/L。